Eeyarestatin causes cervical cancer cell sensitization to bortezomib treatment by augmenting ER stress and CHOP expression.

MLA

Brem, German J., et al. “Eeyarestatin Causes Cervical Cancer Cell Sensitization to Bortezomib Treatment by Augmenting ER Stress and CHOP Expression.” Gynecologic Oncology, vol. 128, no. 2, Feb. 2013, pp. 383–90. EBSCOhost, https://doi.org/10.1016/j.ygyno.2012.10.021.

APA

Brem, G. J., Mylonas, I., & Brüning, A. (2013). Eeyarestatin causes cervical cancer cell sensitization to bortezomib treatment by augmenting ER stress and CHOP expression. Gynecologic Oncology, 128(2), 383–390. https://doi.org/10.1016/j.ygyno.2012.10.021

Chicago

Brem, German J, Ioannis Mylonas, and Ansgar Brüning. 2013. “Eeyarestatin Causes Cervical Cancer Cell Sensitization to Bortezomib Treatment by Augmenting ER Stress and CHOP Expression.” Gynecologic Oncology 128 (2): 383–90. doi:10.1016/j.ygyno.2012.10.021.